Acute inflammatory cardiomyopathy: apparent neutral prognostic impact of immunosuppressive therapy
Eur J Heart Fail
.
2020 Jul;22(7):1280-1282.
doi: 10.1002/ejhf.1821.
Epub 2020 Apr 15.
Authors
Marco Merlo
1
,
Piero Gentile
1
,
Andrea Ballaben
1
,
Jessica Artico
1
,
Matteo Castrichini
1
,
Aldostefano Porcari
1
,
Antonio Cannatà
1
,
Andrea Perkan
1
,
Rossana Bussani
2
,
Gianfranco Sinagra
1
Affiliations
1
Cardiothoracic Department, Azienda Sanitaria Universitaria Integrata di Trieste and University of Trieste, Trieste, Italy.
2
Department of Pathological Anatomy, Azienda Sanitaria Universitaria Integrata di Trieste and University of Trieste, Trieste, Italy.
PMID:
32297411
DOI:
10.1002/ejhf.1821
No abstract available
Publication types
Letter
MeSH terms
Cardiomyopathy, Dilated
Heart Failure*
Humans
Immunosuppressive Agents
Myocarditis* / diagnosis
Prognosis
Substances
Immunosuppressive Agents